Active, not recruitingNot applicableNCT06572982

Extension Study, Pilot, Compassionate Use of Azacitidine 300 mg Film Coated Tablets for Acute Myeloid Leukaemia (AML) Patients

Studying Inherited acute myeloid leukemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hikma Pharmaceuticals LLC
Intervention
Azacitidine(drug)
Enrollment
20 enrolled
Eligibility
18 years · All sexes
Timeline
2025 – 2026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06572982 on ClinicalTrials.gov

Other trials for Inherited acute myeloid leukemia

Additional recruiting or active studies for the same condition.

See all trials for Inherited acute myeloid leukemia →

← Back to all trials